Mirum Pharmaceuticals (MIRM) Research & Development (2019 - 2026)

Mirum Pharmaceuticals' Research & Development history runs 8 years deep, the most recent figure standing at $97.9 million for Q1 2026.

• In Q1 2026, Research & Development rose 138.55% year-over-year to $97.9 million; the TTM figure through Mar 2026 stood at $238.0 million (up 59.28% YoY), while the FY2025 annual figure was $186.2 million, up 32.39% from the prior year.
• Research & Development was $97.9 million for Q1 2026 at Mirum Pharmaceuticals, up from $51.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $97.9 million in Q1 2026 to a low of $22.0 million in Q2 2023.
• Historically, Research & Development has averaged $37.0 million across 5 years, with a median of $31.7 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Research & Development plunged 36.83% in 2022, then soared 138.55% in 2026.
• A 5-year view of Research & Development shows it stood at $31.1 million in 2022, then dropped by 0.55% to $30.9 million in 2023, then soared by 42.32% to $44.0 million in 2024, then grew by 16.08% to $51.1 million in 2025, then soared by 91.58% to $97.9 million in 2026.
• The last three Research & Development figures came in at $97.9 million (Q1 2026), $51.1 million (Q4 2025), and $43.0 million (Q3 2025), per Business Quant data.